These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11868450)

  • 1. [Clinical proarrhythmias induced by anti-arrhythmic drugs, non-cardiovascular agents and implantable cardioverter-defibrillators].
    Fazekas T; Liszkai G
    Orv Hetil; 2002 Jan; 143(2):61-9. PubMed ID: 11868450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-implantable cardioverter-defibrillator interactions.
    Beadle R; Williams L; Lim HS
    Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1267-73. PubMed ID: 20828349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug and defibrillator interactions.
    Carnes CA; Mehdirad AA; Nelson SD
    Pharmacotherapy; 1998; 18(3):516-25. PubMed ID: 9620103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The proarrhythmogenic activity of non-anti-arrhythmia drugs. Is treatment with antihistamines and cisapride safe?].
    Pelov R; Tankova L; Krushkov I
    Vutr Boles; 1999; 31(2-3):5-9. PubMed ID: 10847134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of arrhythmias and use of implantable cardioverter-defibrillators to improve survival in elderly patients with cardiac disease.
    Goldenberg I; Moss AJ
    Clin Geriatr Med; 2007 Feb; 23(1):205-19. PubMed ID: 17126763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between antiarrhythmic drugs and implantable cardioverter-defibrillators.
    Dougherty AH
    Curr Opin Cardiol; 1996 Jan; 11(1):2-8. PubMed ID: 8664528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The principles of pharmacotherapy for arrhythmia at the turn of the millenium].
    Fazekas T; Liszkai G
    Orv Hetil; 1999 Dec; 140(51):2851-9. PubMed ID: 10647274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-arrhythmic drugs interaction and defibrillation threshold in patients with implantable cardioverter defibrillator].
    de Vasconcelos JT; Galvão Filho Sdos S; Barcellos CM
    Arq Bras Cardiol; 2003 Mar; 80(3):336-9. PubMed ID: 12856278
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug-induced arrhythmias].
    Inoue H
    Nihon Rinsho; 1996 Aug; 54(8):2220-6. PubMed ID: 8810801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-wave alternans as a therapeutic marker for antiarrhythmic agents.
    Verrier RL; Nieminen T
    J Cardiovasc Pharmacol; 2010 Jun; 55(6):544-54. PubMed ID: 20555232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arrhythmogenic action of anti-arrhythmia agents. Current clinical view of pro-arrhythmias].
    Fazekas T; Smeets JL; Wellens HJ
    Orv Hetil; 1991 Oct; 132(41):2243-8. PubMed ID: 1945359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.
    Shu J; Zhou J; Patel C; Yan GX
    Pacing Clin Electrophysiol; 2009 Nov; 32(11):1454-65. PubMed ID: 19744278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A focus on when and when not to use antiarrhythmic drugs in treating ventricular arrhythmias and indications for the use of automatic implantable cardioverter-defibrillators.
    Aronow WS
    Geriatrics; 2008 Aug; 63(8):20-8. PubMed ID: 18672953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension and cardiac arrhythmias].
    Vester EG
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maternal cardiac arrhythmias in pregnancy].
    Facchini M; Bauersfeld U; Fasnacht M; Candinas R
    Schweiz Med Wochenschr; 2000 Dec; 130(51-52):1962-9. PubMed ID: 11688063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.